FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
102 letters match. Newest first.
-
DrugsUmicore Argentina S.A.
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
-
DrugsNanjing Hanxin Pharmaceutical Technology Co. Ltd.
FDA warns Nanjing Hanxin of drug-ingredient quality failures and poor supplier oversight; its drugs face U.S. import detention.
High risk -
DrugsChongqing Qiancan Technology Co., Ltd.
Chongqing Qiancan Technology, an API maker in China, refused FDA records requests; FDA placed its drugs on import alert 66-79.
High risk -
DrugsTianjin Healthcare Medical Technology Co., Ltd.
Chinese API maker refused FDA records requests, and all its drugs now face a US import alert.
High risk -
AnimalJohn & Nicole Santos Dairy
John & Nicole Santos Dairy of Hilmar, California sold dairy cows for slaughter containing ampicillin residues above the legal limit.
High risk -
DrugsGraceful Touch, LLC
Graceful Touch marketed 'Herpes B Gone' cream as an unapproved new drug for herpes and STI symptoms, FDA says.
High risk -
DrugsCuria New York, Inc.
FDA warned Curia New York's Rensselaer, New York API plant that undocumented lab injections, shredded records and shared passwords violate CGMP.
High risk -
DrugsKellin Chemicals Co., Ltd. - Zhangjiagang
Kellin Chemicals' API site refused FDA inspection, so FDA calls its drugs adulterated.
High risk -
DrugsShoolin Pharma Chem LLP
Shoolin Pharma Chem, an Indian API maker, warned over filthy conditions, missing test data, and cleaning failures; all U.S. APIs recalled.
High risk -
DrugsTianjin Kilo Pharmaceutical Sci-tech Co., Ltd.
Tianjin Kilo Pharmaceutical Sci-tech, a drug ingredient maker, cited for quality failures and missing listings for demecarium bromide and chlorambucil.
High risk -
DrugsAlmon Healthcare Private Limited
Almon Healthcare, an Indian active pharmaceutical ingredient (API) maker, knowingly used mislabeled, untested raw material and shipped affected drugs to the U.S.
High risk -
DrugsBioMylz Pvt. Ltd.
FDA found destroyed records, inadequate process and cleaning validation, missing microbial testing, and incomplete drug listings at BioMylz, an Indian OTC drug manufacturer.
High risk -
DrugsShimoga Chemicals
FDA warns Shimoga Chemicals of manufacturing quality and data integrity failures in clomiphene citrate active ingredient.
High risk -
DrugsInternational Medication Systems Limited
FDA found insect larvae and heavy microbial growth in International Medication Systems' sterile filling area; its epinephrine injection lot was later recalled.
High risk -
FoodWin Woo Trading, LLC / HF Foods Group
FDA says Win Woo Trading did not develop FSVP for imported gelatin, starches, sugars, teas, rice, beans, and beverage powders.
Medium -
DevicesSkytron, LLC
Skytron marketed four UV disinfection devices without FDA clearance or approval and kept unapproved medical claims after promising to remove them.
High risk -
DrugsIndiangoods.shop
FDA warned website Indiangoods.shop that three herbal sexual-performance capsules it sells are unapproved new drugs.
Medium -
DrugsPharmathen International S.A.
FDA warns Pharmathen over inadequate aseptic controls at its Greek plant making sterile drugs for the U.S.
High risk -
DrugsHubei Gedian Humanwell Pharmaceutical Co., Ltd.
FDA: Hubei Gedian Humanwell API plant has scratched, stained equipment and weak quality unit oversight.
High risk -
DrugsAlchymars ICM SM Private Limited
FDA found Alchymars API manufacturing had poor equipment and facility maintenance, making its APIs adulterated and prompting an import alert.
High risk -
DrugsHarbin Jixianglong Biotech Co., Ltd.
FDA warned Harbin Jixianglong Biotech over CGMP (manufacturing quality rules) failures and misbranded relabeled semaglutide API with false manufacturer labels and missing drug listings.
High risk -
FoodGreat One Trading Inc.
FDA warns Brooklyn importer Great One Trading that it had no foreign supplier verification program for the foods it imports.
Medium -
DrugsHangzhou Yiqi Biotechnology Co., Ltd
FDA cited Hangzhou Yiqi Biotechnology, an API maker in China, for four manufacturing practice failures found in a records review.
High risk -
DrugsActive Cosmetics Manufacturing Inc.
FDA cited Active Cosmetics Manufacturing for releasing topical OTC drugs after microbial contamination without thorough investigations.
High risk -
DrugsAva Inc.
FDA warned Ava Inc. about adulterated drugs after an inspection found data-integrity failures and hidden trial injections in its Willowbrook, Illinois lab.
High risk -
DrugsGuangzhou Huli Technology Co., Ltd. dba Fantasy Face
FDA warned Guangzhou Huli Technology (dba Fantasy Face) for selling an unapproved GLP-1 weight loss drug online.
Medium -
AnimalHenan Lvyuan Pharmaceutical Co. Ltd.
FDA warns Henan Lvyuan Pharmaceutical over CGMP failures at its API plant, including water leaks and incomplete batch records.
High risk -
DrugsImmunityBio, Inc.
FDA says ImmunityBio's Anktiva TV ad and podcast falsely claim it can cure or prevent all cancers.
High risk -
DrugsFlowchem Pharma Private Limited
FDA warned India's Flowchem Pharma over dirty API equipment, exposed materials and untested impurities, and blocked its drug imports.
High risk -
FoodEl Rey USA Meats & Seafood Inc.
FDA found El Rey USA Meats & Seafood lacked required importer verification for shrimp and tilapia.
High risk -
DrugsHTO Nevada, Inc. dba Kirkman
HTO Nevada dba Kirkman, an OTC drug contract manufacturer, was cited for CGMP violations including mislabeled reformulated drugs.
High risk -
DevicesMeridian Bioscience, Inc
FDA warns Meridian Bioscience's Magellan Diagnostics over quality system failures and unreported problems with its blood lead test kits.
High risk -
DrugsChemspec Chemicals Private Limited
FDA warns Indian API maker Chemspec Chemicals over missing batch records and data integrity failures.
High risk -
DevicesASP Global, LLC. dba Anatomy Supply Partners, LLC.
FDA cites ASP Global for quality-system, reporting, and unapproved-change violations involving Safe-T-Fill blood collection devices.
High risk -
DrugsAbsolutely Natural
FDA warned Absolutely Natural of Melbourne, Florida, over nonprescription drug manufacturing violations, including weak contamination investigations and component testing.
High risk -
DrugsDarmerica, LLC
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated/Misbranded
-
DrugsCdymax India Pharma Private Limited
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
-
DrugsSeema International
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
-
DrugsScientific Protein Laboratories, LLC
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
-
Tobaccovapingland.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
DrugsHikal Limited
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
-
DrugsChromatography Institute of America dba Compounder’s International Analytical Laboratory
CGMP/Finished Pharmaceutical/API/Adulterated
-
Tobaccovaping.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
DrugsMentha & Allied Products Private Ltd.
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
-
DrugsYangzhou Sion Commodity Co., Ltd.
CGMP/Finished Pharmaceutical/API/Adulterated
-
DrugsAspen Biopharma Labs Private Limited
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
-
Tobaccovapingby.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
DrugsShree Jaya Laboratories PVT. LTD.
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
-
DrugsTyche Industries Ltd
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
-
DrugsChengdu Innovation Pharmaceutical Co., Ltd.
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated